Founders Capital Management (Texas)’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$771 Hold
6
﹤0.01% 360
2025
Q1
$780 Hold
6
﹤0.01% 347
2024
Q4
$805 Hold
6
﹤0.01% 343
2024
Q3
$886 Hold
6
﹤0.01% 350
2024
Q2
$835 Hold
6
﹤0.01% 351
2024
Q1
$834 Hold
6
﹤0.01% 339
2023
Q4
$825 Hold
6
﹤0.01% 364
2023
Q3
$741 Sell
6
-300
-98% -$37.1K ﹤0.01% 384
2023
Q2
$38.9K Hold
306
0.03% 160
2023
Q1
$40K Sell
306
-17,483
-98% -$2.29M 0.03% 154
2022
Q4
$2.34M Hold
17,789
1.76% 21
2022
Q3
$2.08M Sell
17,789
-2,811
-14% -$329K 1.7% 22
2022
Q2
$2.42M Sell
20,600
-2,205
-10% -$259K 1.91% 20
2022
Q1
$3.48M Hold
22,805
2.23% 17
2021
Q4
$3.48M Sell
22,805
-116
-0.5% -$17.7K 2.23% 17
2021
Q3
$3.71M Sell
22,921
-1,194
-5% -$193K 2.54% 12
2021
Q2
$3.95M Sell
24,115
-290
-1% -$47.5K 2.57% 11
2021
Q1
$3.67M Buy
24,405
+1,535
+7% +$231K 2.62% 16
2020
Q4
$3.47M Buy
+22,870
New +$3.47M 2.45% 14
2020
Q1
$433K Hold
4,020
0.45% 32
2019
Q4
$484K Buy
4,020
+749
+23% +$90.2K 0.37% 36
2019
Q3
$325K Buy
3,271
+380
+13% +$37.8K 0.26% 44
2019
Q2
$315K Buy
2,891
+480
+20% +$52.3K 0.28% 46
2019
Q1
$270K Buy
2,411
+40
+2% +$4.48K 0.25% 49
2018
Q4
$229K Buy
2,371
+80
+3% +$7.73K 0.24% 50
2018
Q3
$279K Buy
2,291
+1,625
+244% +$198K 0.23% 55
2018
Q2
$73K Sell
666
-774
-54% -$84.8K 0.06% 100
2018
Q1
$154K Hold
1,440
0.13% 84
2017
Q4
$154K Hold
1,440
0.13% 86
2017
Q3
$160K Sell
1,440
-90
-6% -$10K 0.13% 89
2017
Q2
$158K Hold
1,530
0.14% 82
2017
Q1
$150K Buy
+1,530
New +$150K 0.13% 87